Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients

Neuromuscular Disorders

Volumn 24, Issue 4, 2014, Pages 347-352

  Mazzone, E ^a   De Sanctis, R ^a   Fanelli, L ^a   Bianco, F ^a   Main, M ^b   Van den Hauwe, M ^c   Ash, M ^b   De Vries, R ^d   Fagoaga Mata, J ^e   Schaefer, K ^f   D'Amico, A ^g   Colia, G ^g   Palermo, C ^a   Scoto, M ^b   Mayhew, A ^h   Eagle, M ^h   Servais, L ⁱ   Vigo, M ^e   Febrer, A ^e   Korinthenberg, R ^f   Jeukens, M ^d   De Viesser, M ^d   Totoescu, A ⁱ   Voit, T ⁱ   Bushby, K ^h   Muntoni, F ^b   Goemans, N ^c   Bertini, E ^g   Pane, M ^a   Mercuri, E ^a   more..

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e HOSPITAL SANT JOAN DE DÉU   (Spain)

^f UNIVERSITY OF FREIBURG   (Germany)

^g BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^h NEWCASTLE UNIVERSITY   (United Kingdom)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Outcome measures; Spinal muscular atrophy

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CORRELATION ANALYSIS; FOLLOW UP; FUNCTIONAL ASSESSMENT; HAMMERSMITH FUNCTIONAL MOTOR SCALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MOTOR FUNCTION MEASURE 20; MOTOR PERFORMANCE; MULTICENTER STUDY; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SPINAL MUSCULAR ATROPHY; STANDING; WALKING DIFFICULTY; CLINICAL TRIAL; COMPARATIVE STUDY; DISABILITY; EUROPE; EVALUATION STUDY; MOTOR ACTIVITY; MUSCULAR ATROPHY, SPINAL; PATHOPHYSIOLOGY; PRESCHOOL CHILD; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISABILITY EVALUATION; EUROPE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MOTOR ACTIVITY; MUSCULAR ATROPHY, SPINAL; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84895795209     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2014.01.003     Document Type: Article

References (25)

1. D'Amico A., Mercuri E., Tiziano F.D., Bertini E. Spinal muscular atrophy. Orphanet J Rare Dis 2011, 6:71.
2. Mercuri E., Bertini E., Iannaccone S.T. Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol 2012, 11:443-452.
3. Kaufmann P., Iannaccone S.T. Clinical trials in spinal muscular atrophy. Phys Med Rehab Clin N Am 2008, 19:653-660.
4. Bertini E., Burghes A., Bushby K., et al. 134th ENMC International workshop: outcome measures and treatment of spinal muscular atrophy, 11-13 February 2005, Naarden, The Netherlands. Neuromuscul Disord 2005, 15:802-816.
5. Iannaccone S.T. Outcome measures for pediatric spinal muscular atrophy. Arch Neurol 2002, 59:1445-1450. American Spinal Muscular Atrophy Randomized Trials Group.
6. Mercuri E., Mayhew A., Muntoni F., et al. Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th-13th May 2007, Naarden, The Netherlands; TREAT-NMD workshop on outcome measures in experimental trials for DMD, 30th June-1st July 2007, Naarden, The Netherlands; conjoint Institute of Myology TREAT-NMD meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France. Neuromuscul Disord 2008, 18:894-903.
7. Main M., Kairon H., Mercuri E., Muntoni F. The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. EJPN 2003, 7:155-159.
8. Berard C., Payan C., Hodgkinson I., Fermanian J. A motor function measure for neuromuscular diseases. Construction and validation study. Neuromuscul Disord 2005, 15:463-470. Group MFMCS.
9. Berard C., Fermanian J., Payan C. Outcome measure for SMA II and III patients. Neuromuscul Disord 2008, 18:593-594.
10. Berard C., Payan C., Fermanian J., Girardot F. A motor function measurement scale for neuromuscular diseases - description and validation study. Revue Neurol 2006, 162:485-493. Groupe d'Etude MFM.
11. Cano S.J., Mayhew A., Glanzman A.M., et al. Rasch analysis of clinical outcome measures in spinal muscular atrophy. Muscle Nerve 2013 July 8.
12. de Lattre C., Payan C., Vuillerot C., et al. Motor function measure: validation of a short form for young children with neuromuscular diseases. Arch Phys Med Rehab 2013 April 18.
13. Mercuri E., Messina S., Battini R., et al. Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study. Neuromuscul Disord 2006, 16:93-98.
14. Vuillerot C., Payan C., Girardot F., et al. Responsiveness of the motor function measure in neuromuscular diseases. Arch Phys Med Rehab 2012, 93:2251-2256.
15. Glanzman A.M., O'Hagen J.M., McDermott M.P., et al. Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III. J Child Neurol 2011, 26:1499-1507.
16. Kaufmann P., McDermott M.P., Darras B.T., et al. Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1year. Arch Neurol 2011, 68:779-786.
17. Kaufmann P., McDermott M.P., Darras B.T., et al. Prospective cohort study of spinal muscular atrophy types 2 and 3. Neurology 2012, 79:1889-1897.
18. Pane M., Staccioli S., Messina S., et al. Daily salbutamol in young patients with SMA type II. Neuromuscul Disord 2008, 18:536-540.
19. Russman B.S., Iannaccone S.T., Samaha F.J. A phase 1 trial of riluzole in spinal muscular atrophy. Arch Neurol 2003, 60:1601-1603.
20. Mercuri E., Bertini E., Messina S., et al. Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. Neurology 2007, 68:51-55.
21. Krosschell K.J., Maczulski J.A., Crawford T.O., Scott C., Swoboda K.J. A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy. Neuromuscul Disord 2006, 16:417-426.
22. Vuillerot C., Payan C., Iwaz J., Ecochard R., Berard C. Responsiveness of the motor function measure in patients with spinal muscular atrophy. Arch Phys Med Rehab 2013, 94:1555-1561. Group MFMSMAS.
23. Mazzone E., Bianco F., Martinelli D., et al. Assessing upper limb function in nonambulant SMA patients: development of a new module. Neuromuscul Disord 2011, 21:406-412.
24. Montes J., McDermott M.P., Martens W.B., et al. Six-minute walk test demonstrates motor fatigue in spinal muscular atrophy. Neurology 2010, 74:833-838.
25. Mazzone E., Bianco F., Main M., et al. Six minute walk test in type III spinal muscular atrophy: a 12month longitudinal study. Neuromuscul Disord 2013, 23:624-628.